Literature DB >> 28233049

A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease.

Samuel Halstrom1,2,3, Catherine L Cherry4,5, Michael Black6, Rachel Thomson1,3, Hayley Goullee7, Svetlana Baltic8, Richard Allcock9,10, Suzanna E L Temple8, Patricia Price11,12.   

Abstract

Despite widespread exposure to potentially pathogenic mycobacteria present in the soil and in domestic water supplies, it is not clear why only a small proportion of individuals contract pulmonary nontuberculous mycobacterial (NTM) infections. Here, we explore the impact of polymorphisms within three genes: P2X ligand gated ion channel 7 (P2X7R), P2X ligand gated ion channel 4 (P2X4R) and calcium/calmodulin-dependent protein kinase kinase 2 beta (CAMKK2) on susceptibility. Thirty single nucleotide polymorphisms (SNPs) were genotyped in NTM patients (n = 124) and healthy controls (n = 229). Weak associations were found between individual alleles in P2X7R and disease but were not significant in multivariate analyses adjusted to account for gender. Haplotypes spanning the three genes were derived using the fastPHASE algorithm. This yielded 27 haplotypes with frequencies >1% and accounting for 63.3% of the combined cohort. In univariate analyses, seven of these haplotypes displayed associations with NTM disease above our preliminary cut-off (p ≤ 0.20). When these were carried forward in a logistic regression model, gender and one haplotype (SH95) were independently associated with the disease (model p < 0.0001; R 2  = 0.05). Examination of individual alleles within these haplotypes implicated P2X7R and CAMKK2 in pathways affecting pulmonary NTM disease.

Entities:  

Keywords:  Genetic polymorphism; Immunogenetics; Non-tuberculous mycobacteria; Pulmonary disease

Mesh:

Substances:

Year:  2017        PMID: 28233049     DOI: 10.1007/s00251-017-0972-z

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  26 in total

1.  Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients.

Authors:  Hayley Goullee; Antonia L Wadley; Catherine L Cherry; Richard J N Allcock; Michael Black; Peter R Kamerman; Patricia Price
Journal:  J Neurovirol       Date:  2016-01-19       Impact factor: 2.643

2.  Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases.

Authors:  Yon Ju Ryu; Eun Joo Kim; Won-Jung Koh; Hojoong Kim; O Jung Kwon; Jung Hyun Chang
Journal:  Clin Vaccine Immunol       Date:  2006-07

Review 3.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

4.  Fusion-activated Ca2+ entry via vesicular P2X4 receptors promotes fusion pore opening and exocytotic content release in pneumocytes.

Authors:  Pika Miklavc; Norbert Mair; Oliver H Wittekindt; Thomas Haller; Paul Dietl; Edward Felder; Melanie Timmler; Manfred Frick
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  Implication of purinergic P2X7 receptor in M. tuberculosis infection and host interaction mechanisms: a mouse model study.

Authors:  André A Santos; Valnês Rodrigues-Junior; Rafael F Zanin; Thiago J Borges; Cristina Bonorino; Robson Coutinho-Silva; Christina M Takyia; Diógenes S Santos; Maria M Campos; Fernanda B Morrone
Journal:  Immunobiology       Date:  2013-03-16       Impact factor: 3.144

6.  Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation.

Authors:  Leanne Stokes; Annmarie Surprenant
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

7.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Authors:  Richard D Kim; David E Greenberg; Mary E Ehrmantraut; Shireen V Guide; Li Ding; Yvonne Shea; Margaret R Brown; Milica Chernick; Wendy K Steagall; Connie G Glasgow; JingPing Lin; Clara Jolley; Lynn Sorbara; Mark Raffeld; Suvimol Hill; Nilo Avila; Vandana Sachdev; Lisa A Barnhart; Victoria L Anderson; Reginald Claypool; Dianne M Hilligoss; Mary Garofalo; Alan Fitzgerald; Sandra Anaya-O'Brien; Dirk Darnell; Rosamma DeCastro; Heather M Menning; Stacy M Ricklefs; Stephen F Porcella; Kenneth N Olivier; Joel Moss; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

Review 8.  The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases.

Authors:  Saleh Al-Muhsen; Jean-Laurent Casanova
Journal:  J Allergy Clin Immunol       Date:  2008-12       Impact factor: 10.793

9.  Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis.

Authors:  Mi-Ae Jang; Su-Young Kim; Byeong-Ho Jeong; Hye Yun Park; Kyeongman Jeon; Jong-Won Kim; Chang-Seok Ki; Won-Jung Koh
Journal:  J Hum Genet       Date:  2013-03-21       Impact factor: 3.172

10.  Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis.

Authors:  Eduardo P Amaral; Simone C M Ribeiro; Verônica R Lanes; Fabrício M Almeida; Marcelle R M de Andrade; Caio Cesar Barbosa Bomfim; Erika M Salles; Karina R Bortoluci; Robson Coutinho-Silva; Mario H Hirata; José M Alvarez; Elena B Lasunskaia; Maria Regina D'Império-Lima
Journal:  PLoS Pathog       Date:  2014-07-03       Impact factor: 6.823

View more
  3 in total

1.  A complete map of the Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) signaling pathway.

Authors:  Mohd Altaf Najar; D A B Rex; Prashant Kumar Modi; Nupur Agarwal; Shobha Dagamajalu; Gayathree Karthikkeyan; Manavalan Vijayakumar; Aditi Chatterjee; Uma Sankar; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2020-11-02       Impact factor: 5.782

Review 2.  Non-tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade-off and NTM ways into virulence.

Authors:  Marisa Cruz-Aguilar; Antonia I Castillo-Rodal; René Arredondo-Hernández; Yolanda López-Vidal
Journal:  Scand J Immunol       Date:  2021-06-22       Impact factor: 3.889

Review 3.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.